.png){kind=icon}
.png){kind=icon}
Return
Nanoengineered Macrophages for in vivo Three-Dimensional Photoacoustic Imaging and Immunotherapy of Acute Lung Injury
.png){kind=icon}
OA
AI
DOI：10.2147/IJN.S608394.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Yibo Tang,1,* Chaohao Liang,1,* Fan Meng,1,2,* Wenjie Yin,1 Fengbing He,1 Jian Zhang1 1School of Biomedical Engineering, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, Guangdong, People’s Republic of China; 2College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China *These authors contributed equally to this work Correspondence: Jian Zhang, School of Biomedical Engineering, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, 1 Xinzhao Road, Xinzhao Town, Panyu District, Guangzhou, Guangdong, People’s Republic of China, Email jianzhang@gzhmu.edu.cn Background: Acute lung injury (ALI) is a life-threatening condition lacking effective real-time monitoring and targeted therapeutic strategies. Cell-based drug delivery systems offer promise but are limited by the inability to track their in vivo distribution and therapeutic response. Methods: Macrophages were engineered to carry aluminum hydroxide-stabilized Tocilizumab (Alum/Toc) and labeled with indocyanine green (ICG) for photoacoustic (PA) imaging. The resulting platform (MΦ/ICG@Alum/Toc) was intravenously administered to Lipopolysaccharides (LPS)-induced ALI mice. Photoacoustic computed tomography (PACT) was used to monitor the dynamic recruitment, pulmonary accumulation, and clearance of the engineered cells over 48 h. Therapeutic efficacy was evaluated by histopathology and lung wet/dry ratio, and biosafety was assessed in major organs. Results: PACT enabled non-invasive, high-resolution tracking of nanoengineered macrophages, revealing rapid homing to inflamed lungs within 6 h, peak accumulation at 24 h, and subsequent hepatic clearance. Three-dimensional (3D) volumetric analysis confirmed targeted pulmonary delivery with minimal off-target distribution. The MΦ/ICG@Alum/Toc platform significantly reduced alveolar edema, inflammatory infiltration, and histopathological scores compared to free Toc, demonstrating superior therapeutic efficacy with excellent biocompatibility. Conclusion: This study establishes PACT as a powerful tool for guiding and monitoring cell-based therapies in real time. The nanoengineered macrophage platform offers a clinically translatable strategy for precision immunotherapy of ALI, with potential applications in other inflammatory diseases. Keywords: nanoengineered macrophages, photoacoustic imaging, acute lung injury, targeted drug delivery, theranostics
Keywords:
nanoengineered macrophages
photoacoustic imaging
acute lung injury
targeted drug delivery
theranostics
Journal
IF:
6.5
Papers:
8.5K
Citations:
4.2W